M. Smyth

Immunology · Nature reviews. Immunology · 2000–2020

A researcher in the Science corpus: 41 papers; trusts 36 researchers and is trusted by 36 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 813 citations into it; #64 of 2,160 by trust here, #38 by citations
• Oncology — 551 citations into it; #63 of 1,698 by trust here, #59 by citations
• Molecular Biology — 278 citations into it; #16,344 of 17,773 by trust here, #4,167 by citations
• Cancer Research — 97 citations into it; #1,767 of 1,780 by trust here, #1,257 by citations
• Physiology — 61 citations into it
• Genetics — 50 citations into it
• Hematology — 24 citations into it; #14 of 225 by trust here, #42 by citations
• Infectious Diseases — 23 citations into it; #154 of 589 by trust here, #402 by citations

Whom M. Smyth trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. G. Dunn
2. A. Cerwenka
3. D. Pardoll
4. Robert Schreiber
5. J. Trapani
6. L. Zitvogel
7. D. Raulet
8. Lloyd J. Old
9. L. Galluzzi
10. Guido Kroemer

Who trusts M. Smyth overall

1. Susan A. Elmore
2. G. Dunn
3. S. Formenti
4. Robert Schreiber
5. Dori A. Thomas
6. I. Waldhauer
7. S. Demaria
8. Mark S. Diamond
9. J. Trapani
10. G. Dranoff

Papers from M. Smyth's perspective

Ordered by how strongly the researchers M. Smyth trusts endorse each paper. Same corpus, a different order for every researcher.

1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
3. Hallmarks of cancer: the next generation. (Cell)
4. Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells (Journal of Experimental Medicine)
5. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (Nature Medicine)
6. Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells (Journal of Experimental Medicine)
7. Immunogenic cell death in cancer therapy. (Annual Review of Immunology)
8. Cell death modalities: classification and pathophysiological implications (Cell Death and Differentiation)
9. Mitochondria and cell death: outer membrane permeabilization and beyond (Nature reviews. Molecular cell biology)
10. Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells (Journal of Experimental Medicine)

Their papers

• Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors (2009) — 1,892 citations
• Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells (2001) — 796 citations
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1 (2002) — 671 citations
• The TRAIL apoptotic pathway in cancer onset, progression and therapy (2008) — 853 citations
• Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) — 916 citations
• Cancer immunoediting and resistance to T cell-based immunotherapy (2018) — 1,476 citations
• Control of Metastasis by NK Cells. (2017) — 645 citations
• Targeting immunosuppressive adenosine in cancer (2017) — 717 citations
• Clinical relevance of host immunity in breast cancer: from TILs to the clinic (2016) — 830 citations
• TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway (2016) — 606 citations
• Combination cancer immunotherapies tailored to the tumour microenvironment (2016) — 846 citations
• Targeting natural killer cells in cancer immunotherapy (2016) — 981 citations
• IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases (2015) — 820 citations
• Classifying cancers based on T cell infiltration and PD-L1 (2015) — 1,297 citations
• Type I interferons in anticancer immunity (2015) — 1,152 citations
• New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape (2014) — 1,411 citations
• Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. (2014) — 1,210 citations
• Translational biology of osteosarcoma (2014) — 1,168 citations
• Consensus guidelines for the detection of immunogenic cell death (2014) — 787 citations
• Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (2014) — 997 citations